Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -10.60% vs -58.11% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 4.18% vs 71.60% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 63.08% vs -42.78% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 91.77% vs -6.75% in Mar 2024
Compare Balance Sheet Results of Ajooni Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
34.45
3.09
31.36
1,014.89%
Share Warrants & Outstandings
Total Reserve
53.63
68.71
-15.08
-21.95%
Shareholder's Funds
88.08
71.80
16.28
22.67%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.94
0.00
1.94
0.00%
Secured Loans
1.94
0.00
1.94
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.38
0.11
-0.49
-445.45%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.21
0.00
0.21
0.00%
Total Non-Current Liabilities
1.77
0.11
1.66
1,509.09%
Current Liabilities
Trade Payables
3.50
38.70
-35.20
-90.96%
Other Current Liabilities
1.32
0.94
0.38
40.43%
Short Term Borrowings
0.00
9.91
-9.91
-100.00%
Short Term Provisions
0.01
0.02
-0.01
-50.00%
Total Current Liabilities
4.82
49.58
-44.76
-90.28%
Total Liabilities
94.67
121.49
-26.82
-22.08%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
17.18
16.85
0.33
1.96%
Less: Accumulated Depreciation
5.76
6.37
-0.61
-9.58%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
11.41
10.48
0.93
8.87%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.29
0.00
0.29
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.49
3.44
0.05
1.45%
Long Term Loans & Advances
17.47
0.75
16.72
2,229.33%
Other Non Current Assets
0.00
3.46
-3.46
-100.00%
Total Non-Current Assets
32.67
18.13
14.54
80.20%
Current Assets Loans & Advances
Current Investments
0.00
0.36
-0.36
-100.00%
Inventories
23.99
38.01
-14.02
-36.89%
Sundry Debtors
16.22
56.54
-40.32
-71.31%
Cash and Bank
6.83
0.16
6.67
4,168.75%
Other Current Assets
2.02
0.17
1.85
1,088.24%
Short Term Loans and Advances
12.95
8.13
4.82
59.29%
Total Current Assets
62.00
103.36
-41.36
-40.02%
Net Current Assets (Including Current Investments)
57.18
53.78
3.40
6.32%
Total Current Assets Excluding Current Investments
62.00
103.00
-41.00
-39.81%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
94.67
121.49
-26.82
-22.08%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.94
9.91
-7.97
-80.42%
Book Value per share (adjusted)
5.11
232.39
-227.28
-97.80%
Annual - Borrowings
Borrowings 1.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -10.60% vs -58.11% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 11.71 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.18% vs 71.60% in Mar 2024
Annual - Investments
Investments 3.49 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 63.08% vs -42.78% in Mar 2024
Annual - Current Assets
Current Assets 62.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 91.77% vs -6.75% in Mar 2024






